The EBMT

02/04/2026

Missed your chance to attend the 52nd Annual Meeting of the EBMT? 🧑‍⚕️

🔓 Unlock the Annual Meeting's best content from anywhere in the world with virtual on-demand access to watch the recordings via the Virtual Meeting Platform or the EBMT 2026 App.

💻 Purchase access to watch the on-demand recordings until 25 April 2026 at 23:59 CEST ⬇️
https://www.ebmt.org/annual-meeting/on-demand

🖱️ Discounts available for EBMT Members, LMIC Residents and Quality Management Day Pass.

✅ Plus, earn up to 26 EBAH-CME credit points by watching the on-demand content.

Please note that some sessions and presentations are pending review and that some speakers may not consent to the publication of their content on-demand.

01/04/2026

01/04/2026

📢 Don’t forget to nominate your touchHAEMATOLOGY Future Leaders 2026!

Last year, we recognized Dr Carmelo Gurnari as a Future Leader 2025 for his achievements in the field of head and neck cancer:

“I am delighted to have been nominated in 2025 by touchHAEMATOLOGY as a Future Leader in the field! By bridging the gap between basic science and clinical practice, empowering junior members and strengthening international collaborations, my goal in haematology is to translate the new evidence of molecular biology into practice-changing innovations.”

Is there a rising star you think should be on our 2026 list?

✨ Make your nomination today: https://touchhaematology.com/insight/nominate-a-rising-star-for-touchhaematology-future-leaders-2026/

📄Revisit our 2025 list: https://touchhaematology.com/insight/touchhaematology-future-leaders-2025/

01/04/2026

📣 Final chance to save $50 on Early Bird registration 🎫

From 28-29 May, American Society for Transplantation and Cellular Therapy and The EBMT will bring together a select community of leading scientists and clinicians in Philadelphia, USA for the 5th edition of the Basic and Translational Scientific Meeting. This highly collaborative conference is dedicated to accelerating progress and discovery in hematopoietic cell transplantation and related cellular therapies.

Unlike large conferences, this meeting is intentionally limited to just 100 participants. The smaller format encourages deeper discussion, meaningful collaboration and mentorship opportunities that help shape the next generation of research.

If you are looking for high-value scientific exchange, direct access to peers and a setting built for discovery, this is the meeting to attend.

Register with the Early Bird discount by tomorrow, 2 April 2026 at 17:00 CST ⬇️
https://www.ebmt.org/events/5th-joint-astct-ebmt-basic-and-translational-scientific-meeting

25/03/2026

Thank you, EBMT Community, for making an amazing congress. 🤩🎬

We hope you enjoyed being in as much as we did these past 4 days. 👍

Together we keep Advancing the Art of Patient Care. 🎨⚕️🫶

25/03/2026

We hope you made unique memories at EBMT 2026. 🎞️🌟

If this was your first Annual Meeting, we are delighted to welcome new faces to our . 🌐

With over 600 presentations, 550 faculty, 220 oral presenters, 870 posters and 4,800 healthcare plus allied health professionals in , there’s something for everyone at our Annual Meeting. 🧑‍⚕️✅

Safe travels home and we hope to see you for in Rotterdam! 👋

25/03/2026

The future of medicine is built together .

🤝 At EBMT 2026, young ambassadors, academic leaders and public institution representatives came together in one shared space and with one shared purpose: supporting the next generation of doctors and advancing the Art of patient care. 🧬

25/03/2026

🎟️ Congratulations to our three raffle winners at EBMT 2026 :

Hatice Ilgen Sasmaz (Turkey)
Charlotte Rigby (United Kingdom)
Maria Queralt Salas Gay (Spain)

who have won free registration for next year’s Annual Meeting .

🎉 See you at the next edition.

25/03/2026

Recognising excellence in research .

🏅 Van Bekkum Award
Is awarded to Roni Shouval (USA) for the study:
High-Throughput Deep Learning-Based Profiling Of CAR-T Immune Dynamics From Routine Peripheral Blood Smears.

🏅 Basic Science Award
Is awarded to Ane Altuna Mongelos (Spain) for the study:
CD19/CD84 If-Better Dual CAR T Cells Demonstrate Superior Control Of CD19-Low B-All Than Single CART19.

Discover more about this research:
https://ebmt2026.abstractserver.com/programme/ #/details/presentations/1001

https://ebmt2026.abstractserver.com/programme/ #/details/presentations/1016

25/03/2026

Jon J. van Rood Award .

Julius Fischer discusses the research that earned him the Jon J. van Rood Award, highlighting how insights into immune responses and tissue regeneration may improve outcomes in transplantation and cancer therapy.

👉 Explore the full interview via the link below.
https://www.ebmt.org/ebmt/news/ebmt-2026-annual-meeting-jon-j-van-rood-award-winner-julius-fischer